MetS and cardiovascular risk factors among Palestinians of East Jerusalem

Eastern Mediterranean Health Journal

Volumn 15, Issue 6, 2009, Pages 1464-1473

  Abu Sham'a, R A H ^a   Darwazah, A K ^a   Kufri, F H ^a   Yassin, I H ^a   Torok, N I ^a  

^a Makassed Hospital   (Palestine)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRY; ARAB; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MIDDLE EAST; OBESITY; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; URBAN HEALTH;

EID: 75449119111     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kahn R et al. The metabolic syndrome: time for critical appraisal. Joint Statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia, 2005, 48:1684-99.
2. Isomma B et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes care, 2001, 24:683-9.
3. Grundy S et al. Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation, 2004, 1:243-53.
4. Kark JD, Gordon ES, Hakli Z. Coronary heart disease mortality among Arab and Jewish residents of Jerusalem. Lancet, 2000, 356:1410-1.
5. Abdul-Rahim HF et al. The metabolic syndrome in the West Bank Population. An urban and rural comparison. Diabetes care, 2001, 24:275-9.
6. Abdul-Rahim HF et al. Obesity in a rural and urban Palestinian West Bank population. International journal of obesity, 2003, 27:140-6.
7. Abdul-Rahim HF et al. Obesity and selected co-morbidities in an urban Palestinian population. International journal of obesity, 2001, 25:1736-40.
8. Consensus worldwide definition of the metabolic syndrome. Brussels, International Diabetes Federation, 2006 (http://www.idf.org/webdata/ docs/IDF-Meta-def-final.pdf, accessed 4 March 2009).
9. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Bethesda, Maryland, National Heart, Lung, and Blood Institute, 2003.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 1972, 18:499-502.
11. Thompson PD et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Circulation, 2003, 107:3109-16.
12. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology, 2005, 30:1-10.
13. Al-Latawi JA et al. Prevalence of the metabolic syndrome among Omani adults. Diabetes care, 2003, 26:1781-5.
14. Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabetic medicine, 2006, 23:441-4.
15. Jaber LA et al. The prevalence of the metabolic syndrome among Arab Americans. Diabetes care, 2004, 27:234-8.
16. Kaluski DN, Berry EM. Prevalence of obesity in Israel. Obesity reviews, 2005, 6:115-6.
17. Lam KS et al. Obesity as the key player in the metabolic syndrome. International Congress Series, 2004, 1262:542-5 (Atherosclerosis XIII. Proceedings of the 13th International Atherosclerosis Symposium).
18. Ajlouni K, Jaddou H, Batieha A. Diabetes and impaired glucose tolerance in Jordan: Prevalence and associated risk factors. Journal of internal medicine, 1998, 244:317-23.
19. Hirbali KI et al. Prevalence of diabetes in greater Beirut. Diabetes care, 2005, 28:1262.
20. Abdella N et al. Non-insulin-dependent diabetes in Kuwait: prevalence rates and associated risk factors. Diabetes research and clinical practice, 1998, 42:187-96.
21. Malik M et al. Glucose intolerance and associated factors in multi-ethnic population of the United Arab Emirates: Result of a national survey Diabetes research and clinical practice, 2005, 69:188-95.
22. Al-Moosa S et al. Diabetes and urbanization in the Omani population: an analysis of national survey. Population health metrics, 2006, 4(1):5.
23. Al-Mahroos F, McKeigue PM. High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes care, 1998, 21:936-42.
24. Husseini A et al. Prevalence of diabetes mellitus and impaired glucose tolerance in a rural Palestinian population. Eastern Mediterranean health journal, 2000, 6:1039-45.
25. Abdul-Rahim HF et al. Diabetes mellitus in an urban Palestinian population: Prevalence and associated factors. Eastern Mediterranean health journal, 2001, 7:67-78.
26. McIntyre EA, Walker M. Genetics of type 2 diabetes and insulin resistance: knowledge from human studies. Clinical endocrinology, 2002, 57:303-11.
27. Plan of Action for Tobacco Control in the Eastern Mediterranean Region. Eastern Mediterranean health journal, 1997, 3:168-75.
28. Leenen FH. Cardiovascular consequences of sympathetic hyperactivity. Canadian journal of cardiology, 1999, 15(Suppl. A):2A-7A.
29. Ginsburg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. Journal of cardiovascular risk, 2000, 7:325-31.
30. Otvos J et al. LDL particles, but not LDL cholesterol, are highly elevated in the metabolic syndrome: results from the Framingham Offspring Study. Circulation, 2003, 108 (Suppl. 4):740-1.
31. Rosenson RS. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome. Current problems in cardiology, 2005, 30:241-79.
32. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. American journal of hypertension, 2003, 16:952-8.
33. Rutter MK et al. C-reactive protein, the metabolic syndrome and the prediction of cardiovascular events in the Framing-ham Offspring Study. Circulation, 2004, 110:380-5.
34. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: Findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis, 2003, 168:351-8.
35. Facchini F et al. Demonstration of the relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. Journal of internal medicine, 1992, 232:267-72.
36. Targher G et al. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. Journal of internal medicine, 1996, 239:435-41.